secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2026-07-15T20:23:33+00:00
Accession:  0001193125-26-304812
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RxSight appoints Aziz Mottiwala as CEO; founder Ron Kurtz becomes CMO effective July 20, 2026
--------------------------------------------------------------------------------

- Mottiwala receives $750k base salary, 90% target bonus, and $14M in equity ($2M option + $12M RSU).
- Kurtz transitions to CMO with $740k salary, up to 100% bonus, four $370k retention bonuses, and 500k RSU award.
- Kurtz resigns from Board; Mottiwala appointed to fill vacancy as Class II director.
- Board adopts 2026 Inducement Plan reserving 3.5M shares for new-hire equity grants.
- Company states it is not updating previously communicated financial guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000119312526304812/0001193125-26-304812-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000119312526304812/d140030d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-304812

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer